University of Cambridge > Talks.cam > SciBar Cambridge > Engineering Immunity: T cell-driven immunotherapy and the future of medicine

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Engineering Immunity: T cell-driven immunotherapy and the future of medicine

Download to your calendar using vCal

If you have a question about this talk, please contact Vasee .

Michael Harris, PhD student at the Department of Medicine, will talk about his study on T cell activation. T cells are key effectors and regulators of the immune response to infections and cancer. Recent decades have seen our understanding of the molecular mechanisms of T cell activation advance significantly. This knowledge is being used to engineer patient-specific immunotherapies and circumvent cancer’s immune-evasions mechanisms.

This talk is part of the SciBar Cambridge series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

English Faculty, GR05 Queen's Building Auditorium, Emmanuel College, CB2 3AP http://www.emma.cam.ac.uk/conferences/maps/ john

Other talks

TBC Organiser Welcome "Gods, Monsters & Middle-class Uncles: Indian Comics in a Time between Worlds" Washing machines and their rare components: lessons from kidney patients Title to be confirmed Group Work
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity